Skip to main content
. 2019 Sep 28;9(2):53–64. doi: 10.15171/ijhpm.2019.76

Table 3. Frequency Distribution of New Acceptors by Method Uptake (LARCs and Short-Acting Methodsa) Disaggregated by Intervention Periodb .

Intervention Period Before
No. (%)
After
No. (%)
P Value
Health Center - 1 .86
LARCs 6 (10.2) 10 (11.1)
Short-acting methods 53 (89.8) 80 (88.9)
Health Center - 2 .66
LARCs 29 (54.7) 44 (58.7)
Short-acting methods 24 (45.3) 31 (41.3)
Health Center - 3 .17
LARCs 44 (28.6) 26 (21.3)
Short-acting methods 110 (71.4) 96 (78.7)
Health Center - 4 .05
LARCs 66 ( 37.1) 37 (50.7)
Short-acting methods 112 (62.9) 36 (49.3)
Health Center – 5 .11
LARCs 97 (50.8) 52 (41.6)
Short-acting methods 94 (49.2) 73 (58.4)
Health Center - 6
.65
LARCs 121 (46.4) 84 (48.6)
Short-acting methods 140 (53.6) 89 (51.4)
Health Center - 7
.52
LARCs 16 (22.5) 10 (17.9)
Short-acting methods 55 (77.5) 46 (82.1)
Health Center - 8
.01
LARCs 12 (15.2) 24 (33.8)
Short-acting methods 67 (84.8) 47 (66.2)

Abbreviation: LARCs, implants and intrauterine devices.

a Short-acting methods: injectables, oral contraceptives, and condoms (male); emergency contraceptives not reported by any health center.

b Intervention period: 6 months before (Before); 6 months after (After) LARCs Training.